Olink

Olink®
Part of Thermo Fisher Scientific

Blog

Read how Olink’s next-generation proteomics technology enables scientists to better understand disease biology, improve stratification of patient populations, and drive improvements in the development of new and more effective therapeutics.

 

Filters

PostApplication areaDisease areaBlog typeProducts

Publication highlights April 2025

Products

Integrating Mass Spectrometry and Affinity-Based Proteomics

Evaluating CAR T-Cell Therapy Toxicity

Products

Established and emerging biomarkers in immuno-oncology: New Insights from the UK Biobank Pharma Proteomics Project

Products

A pivotal moment for biomedical science

Products

Publication highlights update - January 2025

Products

Publication highlights February 2025 - Proteomics in mental health

Products

Publication highlights March 2025

Products

Gaining deeper biological insights from challenging samples

Protein signatures outperforming individual biomarkers for improved clinical outcomes

A stepwise guide to navigating multiplex immunoassay data analysis

Publication highlights June 2024 These are just some selected articles to highlight from a wealth of recent publications citing the use of Olink's PEA technology.

Publication highlights update - November 2024

Publication highlights update - October 2024

Celebrating 2000 publications citing Olink

Publication highlights July 2024

Publication highlights June 2024

Olink Insight Unveils Open-access Map of the Human Proteome, Aiding Biomarker Discovery and Understanding of Disease

Access our latest E-book: Empowering genomics with high-throughput proteomics

Novogene Asia Pacific Middle East and Africa adopts Olink Explore HT technology to accelerate multi-omics research with next generation proteomics

28 blogs